KKR, the global investment giant, has launched Allyntra as a new, precision-engineered solutions platform for the medtech industry while also announcing several senior management changes.
Source: FierceBiotech
You may also like
Macrophage Membrane-Derived Nanoparticles Shows...
Stem Cell Therapy Shows Promise in First Human...
Ag Genomics Begins to Bear Fruit
StockWatch: Insilico Projects Profit, Revenue Leaps as...
[Podcast] From Protocol to Patient: Inside Clinical...
‘How did they get there first?’ Biotechs forced to...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.